A story in Forbes takes a look at the trend of top global brands issuing public apologies for serious missteps.
The story picks out Johnson & Johnson as an example of a company falling back on a new branding campaign in an effort to win back customers who have turned away because of recent problems.
In Johnson & Johnson’s case, those problems included a string of recalls, including both over-the-counter medicines and ...
continue reading...
A news release from Johns Hopkins goes into detail about a study, led by one of the institution’s researchers, which concluded that people taking the diabetes medications Byetta and Januvia are twice as likely to be hospitalized with pancreatitis.
Pancreatitis is an inflammation of the pancreas that’s often a precursor to pancreatic cancer.
Results of the study were published online in the medical journal JAMA Internal Medicine. Researchers concluded that sitagliptin and ...
continue reading...
Sixty three recipients of an artificial hip implant manufactured by a Johnson & Johnson subsidiary have filed suit in Israeli court, claiming that the devices broke down and caused them pain and a high level of metal ions in their blood.
According to a report in Jewish Business News, the plaintiffs “describe attendant problems in functioning accompanied by infections, tumors, fractures ...
continue reading...
A federal judge overseeing more than 50 consolidated lawsuits about the Mirena intrauterine device recommends that the plaintiff’s lawyers include some women in the proposed leadership committee, according to a Reuters report.
U.S. District Judge Cathy Seibel made that recommendation during the multidistrict litigation’s first status conference in White Plains, New York, when four male lawyers asked to be appointed to the litigation’s executive committee. Given the nature of the ...
continue reading...
A piece in the New York Times on Johnson & Johnson’s new corporate branding campaign says the company urgently needed to distance itself from the “bad press of product recalls and pending litigation,” of which it experienced much lately.
In 2010, the story points out, Johnson & Johnson’s McNeil Consumer Healthcare unit recalled more than 280 million packages of over-the-counter medications including Motrin, children’s Tylenol liquid and Benadryl.
Also in 2010, the ...
continue reading...
A new study by Canadian researchers adds to a growing pool of evidence that Lipitor and other types of cholesterol-lowering drugs called statins put patients at a higher risk of developing diabetes.
According to a story on CTV News, researchers published the results of their study in BMJ, a journal of the British Medication Association.
The story notes that previous research has spotlighted a possible link between taking some statins and diabetes, ...
continue reading...
